news
« BACK
Pharmacology - Health - 21.09.2023 
Salting less could prevent 5,300 deaths a year in Canada
This figure represents around 9% of deaths caused by cardiovascular disease in Canada each year. Reducing our salt intake to the level recommended by public health authorities could prevent up to 5,300 deaths per year in Canada. This is the conclusion reached by a research team at the end of a study evaluating the impact of different scenarios for reducing sodium consumption on the health of the Canadian population.
Health - Pharmacology - 14.09.2023 
New variants, new vaccines. Here’s what you should know about COVID-19 going into fall
Science, Health & Technology Brett Goldhawk As we head into fall, cases of COVID-19 are once again rising across Canada, fuelled by new variants that are offshoots of the original Omicron variant. At the same time, Canada is rolling out an updated suite of vaccines that are more tailored to currently circulating strains of the virus.
Pharmacology - Health - 03.08.2023 
Modern antidepressants may reduce risk of relapse for patients with bipolar depression
Science, Health & Technology Brett Goldhawk Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British Columbia. The findings, published today in the New England Journal of Medicine , challenge current clinical practice guidelines and could change how bipolar depression is managed globally.
Pharmacology - Health - 01.08.2023 
New method helps to determine what medications breastfeeding mothers can take
Waterloo Pharmacy researchers address significant gap in maternal medication research. It's the start of World Breastfeeding Week, and University of Waterloo Pharmacy researchers have developed a novel metric for an underserved research area to aid healthcare providers in advising on maternal medication use for breastfeeding mothers or nursing persons.
Pharmacology - Health - 25.07.2023 
Researchers developing first drug of its kind to treat incurable eye diseases
Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human trials. Neovascular age-related macular degeneration (AMD) affects more than 200 million people worldwide.
Health - Pharmacology - 25.07.2023 
Medications to treat alcohol addiction underused
Science, Health & Technology Kevin Hollett Medications for alcohol use disorder are underutilized in British Columbia, despite their safety and effectiveness, according to a new study published today in the journal Addiction . The study found that between 2015 and 2019 fewer than five per cent of British Columbians who met the criteria for moderate to severe alcohol use disorder (AUD) received medications for the minimum recommended time of three months.
Health - Pharmacology - 19.07.2023 
Molecule with promise to enhance vaccine efficacy
Western researchers discover molecule with promise to enhance vaccine efficacy Findings have significant implications for strengthening the global response to current and future viral threats Taking a significant leap in the field of vaccine development, Western researchers have discovered a potential 'super molecule' that can bolster the effectiveness of several vaccines against viral diseases, including influenza, COVID-19 and smallpox.
Health - Pharmacology - 19.07.2023
Health - Pharmacology - 13.07.2023
Pharmacology - Health - 12.07.2023 
Against the grain strategy to improve cancer treatment
Chemotherapy is a life-saving treatment for many cancer patients. Unfortunately, many cancer drugs also cause cancer cells to mutate, which over time leads them to become more aggressive and harder to treat. SFU Molecular Biology and Biochemistry researcher Mani Larijani is exploring an unconventional approach to address this issue and improve treatment outcomes for cancer patients.
Health - Pharmacology - 03.07.2023 
New insights from study could help understand long COVID better
Western researchers find unique blood plasma protein patterns in patients with prolonged fatigue, brain fog Using advanced research techniques, including a form of artificial intelligence, a team of researchers has discovered unique patterns of blood plasma proteins in patients with suspected long COVID that could improve patient outcomes.
Pharmacology - Health - 21.06.2023 
AI use in pharmacotherapy still in the early stages
AI promises to transform drug development and dispensing, but many challenges first need to be overcome. An overview. Detecting drug interactions, discovering new drugs, predicting treatment response, optimizing doses-the list of the potential benefits of artificial intelligence (AI) for pharmacotherapy is long and promising.
Health - Pharmacology - 20.06.2023 
A protein helps HIV remain silent
Researchers in Montreal and Brussels have identified a molecule that allows HIV to evade the immune system and that may prove to be a good therapeutic target. Throughout the course of antiretroviral therapy, HIV hides quietly in reservoirs inside CD4+ T lymphocytes, white blood cells that play a role in activating the immune system against infection.
Health - Pharmacology - 13.06.2023 
Rare isotopes as a tool in the fight against cancer
New study uses rare isotopes as a tool in the fight against cancer Specially designed molecules seek out and deliver radioactive isotopes directly to cancer cells In a national multi-centre study, scientists at Western and Lawson Health Research Institute are working to create rare isotopes that will be used as an important tool to help treat cancer.
Pharmacology - Health - 06.06.2023
Health - Pharmacology - 01.06.2023
Health - Pharmacology - 30.05.2023
Health - Pharmacology - 17.05.2023 
Novel treatment for recurrent glioblastoma shows promising results
An international clinical trial led by researchers at University Health Network (UHN) and the University of Toronto has shown that a new therapy for recurrent glioblastoma prolongs patient survival, in some cases by several years.
Health - Pharmacology - 10.05.2023 
Potential Life-Saving Results in Treating Cardiac Arrhythmias
Drug Discovered by SFU Researchers Shows Potential Life-Saving Results in Treating Cardiac Arrhythmias Scientists at Simon Fraser University (SFU) and the Lankenau Institute for Medical Research (LIMR) near Philadelphia have found that a drug discovered at SFU and patented several years ago may have potential lifesaving results in the treatment of conditions leading to sudden cardiac death.
Pharmacology - Health - 26.04.2023 
Innovative treatment targets blood clots without increased bleeding risk
Science, Health & Technology Erik Rolfsen Safer and more effective blood thinners could be on the way following a groundbreaking discovery by researchers at UBC and the University of Michigan, published today in Nature Communications . By combining their expertise in blood clotting systems and chemical synthesis, the researchers have designed a new compound called MPI 8 that offers the potential to prevent blood clots without any increased risk of bleeding-a common side effect of existing blood thinners.
Pharmacology
Results 1 - 20 of 76.
This figure represents around 9% of deaths caused by cardiovascular disease in Canada each year. Reducing our salt intake to the level recommended by public health authorities could prevent up to 5,300 deaths per year in Canada. This is the conclusion reached by a research team at the end of a study evaluating the impact of different scenarios for reducing sodium consumption on the health of the Canadian population.
Science, Health & Technology Brett Goldhawk As we head into fall, cases of COVID-19 are once again rising across Canada, fuelled by new variants that are offshoots of the original Omicron variant. At the same time, Canada is rolling out an updated suite of vaccines that are more tailored to currently circulating strains of the virus.
Science, Health & Technology Brett Goldhawk Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British Columbia. The findings, published today in the New England Journal of Medicine , challenge current clinical practice guidelines and could change how bipolar depression is managed globally.
Waterloo Pharmacy researchers address significant gap in maternal medication research. It's the start of World Breastfeeding Week, and University of Waterloo Pharmacy researchers have developed a novel metric for an underserved research area to aid healthcare providers in advising on maternal medication use for breastfeeding mothers or nursing persons.
Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human trials. Neovascular age-related macular degeneration (AMD) affects more than 200 million people worldwide.
Science, Health & Technology Kevin Hollett Medications for alcohol use disorder are underutilized in British Columbia, despite their safety and effectiveness, according to a new study published today in the journal Addiction . The study found that between 2015 and 2019 fewer than five per cent of British Columbians who met the criteria for moderate to severe alcohol use disorder (AUD) received medications for the minimum recommended time of three months.
Western researchers discover molecule with promise to enhance vaccine efficacy Findings have significant implications for strengthening the global response to current and future viral threats Taking a significant leap in the field of vaccine development, Western researchers have discovered a potential 'super molecule' that can bolster the effectiveness of several vaccines against viral diseases, including influenza, COVID-19 and smallpox.
McGill University and Moderna to expand collaborations with new projects in Lipid Nanoparticle research
Two projects will analyze characteristics of lipid nanoparticles as well as naturally occurring particles known as Extracellular Vesicles (EVs) McGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs).
Two projects will analyze characteristics of lipid nanoparticles as well as naturally occurring particles known as Extracellular Vesicles (EVs) McGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs).
A stronger placebo effect for those who believe sham medical treatments are personalized
If you believe a medical treatment was developed specifically for you, it may be more effective, especially if you want to be seen as unique, according to new research from McGill University. In two studies, researchers in the Department of Psychology found that participants who thought a medical device that was really a placebo was personalized to their genetic makeup and physiology reported feeling less pain when using it, compared to those who believed it was a standard treatment.
If you believe a medical treatment was developed specifically for you, it may be more effective, especially if you want to be seen as unique, according to new research from McGill University. In two studies, researchers in the Department of Psychology found that participants who thought a medical device that was really a placebo was personalized to their genetic makeup and physiology reported feeling less pain when using it, compared to those who believed it was a standard treatment.
Chemotherapy is a life-saving treatment for many cancer patients. Unfortunately, many cancer drugs also cause cancer cells to mutate, which over time leads them to become more aggressive and harder to treat. SFU Molecular Biology and Biochemistry researcher Mani Larijani is exploring an unconventional approach to address this issue and improve treatment outcomes for cancer patients.
Western researchers find unique blood plasma protein patterns in patients with prolonged fatigue, brain fog Using advanced research techniques, including a form of artificial intelligence, a team of researchers has discovered unique patterns of blood plasma proteins in patients with suspected long COVID that could improve patient outcomes.
AI promises to transform drug development and dispensing, but many challenges first need to be overcome. An overview. Detecting drug interactions, discovering new drugs, predicting treatment response, optimizing doses-the list of the potential benefits of artificial intelligence (AI) for pharmacotherapy is long and promising.
Researchers in Montreal and Brussels have identified a molecule that allows HIV to evade the immune system and that may prove to be a good therapeutic target. Throughout the course of antiretroviral therapy, HIV hides quietly in reservoirs inside CD4+ T lymphocytes, white blood cells that play a role in activating the immune system against infection.
New study uses rare isotopes as a tool in the fight against cancer Specially designed molecules seek out and deliver radioactive isotopes directly to cancer cells In a national multi-centre study, scientists at Western and Lawson Health Research Institute are working to create rare isotopes that will be used as an important tool to help treat cancer.
Programmable 3D printed wound dressing could improve treatment for burn, cancer patients
Researchers have developed intelligent hydrogel materials for use as a reusable wound dressing One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful. To bring relief to this and other problems, University of Waterloo researchers have created a new type of wound dressing material using advanced polymers.
Researchers have developed intelligent hydrogel materials for use as a reusable wound dressing One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful. To bring relief to this and other problems, University of Waterloo researchers have created a new type of wound dressing material using advanced polymers.
Antipsychotic drug use increased in Canadian long-term care homes in first year of pandemic
Other aspects of treatment in long-term care homes generally remained the same a year into the pandemic While most aspects of care quality in long-term care homes did not differ in the first year of the pandemic from pre-pandemic levels, a new study shows that the use of antipsychotic drugs increased in all provinces.
Other aspects of treatment in long-term care homes generally remained the same a year into the pandemic While most aspects of care quality in long-term care homes did not differ in the first year of the pandemic from pre-pandemic levels, a new study shows that the use of antipsychotic drugs increased in all provinces.
Biomarkers for the Progression of Type 2 Diabetes Identified
Researcher Guy Rutter and his colleagues in Europe, Canada and the United States have discovered molecules in samples taken from 3,000 diabetic patients that could help personalize treatments. Guy Rutter, researcher at the Centre de recherche du CHUM (CRCHUM), Imperial College London and professor in the Department of Medicine at the Université de Montréal Credit: CRCHUM This research was carried out as part of the European RHAPSODY project (Risk Assessment and Progression of Diabetes).
Researcher Guy Rutter and his colleagues in Europe, Canada and the United States have discovered molecules in samples taken from 3,000 diabetic patients that could help personalize treatments. Guy Rutter, researcher at the Centre de recherche du CHUM (CRCHUM), Imperial College London and professor in the Department of Medicine at the Université de Montréal Credit: CRCHUM This research was carried out as part of the European RHAPSODY project (Risk Assessment and Progression of Diabetes).
An international clinical trial led by researchers at University Health Network (UHN) and the University of Toronto has shown that a new therapy for recurrent glioblastoma prolongs patient survival, in some cases by several years.
Drug Discovered by SFU Researchers Shows Potential Life-Saving Results in Treating Cardiac Arrhythmias Scientists at Simon Fraser University (SFU) and the Lankenau Institute for Medical Research (LIMR) near Philadelphia have found that a drug discovered at SFU and patented several years ago may have potential lifesaving results in the treatment of conditions leading to sudden cardiac death.
Science, Health & Technology Erik Rolfsen Safer and more effective blood thinners could be on the way following a groundbreaking discovery by researchers at UBC and the University of Michigan, published today in Nature Communications . By combining their expertise in blood clotting systems and chemical synthesis, the researchers have designed a new compound called MPI 8 that offers the potential to prevent blood clots without any increased risk of bleeding-a common side effect of existing blood thinners.
